Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
We provide comprehensive care for individuals who are newly diagnosed or living with neuroendocrine tumors. Led by our medical oncology neuroendocrine tumor experts, our multispecialty team works together to care for patients throughout their treatment journey. Our focus is on providing leading-edge care for the best possible outcomes, which includes access to the latest diagnostic technology, treatments, and clinical trials.
The Neuroendocrine Tumor Program offers a team of Stanford doctors—from medical and surgical oncology, endocrinology, radiology, interventional radiology, nuclear medicine, colorectal surgery, and cancer genetics—who work together to care for you throughout your treatment journey.
Our medical oncology experts coordinate and direct a comprehensive care plan for you, applying the latest, advanced treatments and research for neuroendocrine tumors. As a Stanford patient, you also have access to clinical trials testing new treatments.
The team works in collaboration with community oncologists to provide you with additional care and support close to home. We also provide second opinions for those diagnosed with neuroendocrine tumors, who are evaluating their treatment options.
Specialized Survivorship Plan
Our focus is to provide leading-edge care for the best possible outcomes. The Neuroendocrine Tumor Program provides ongoing support with a written survivorship plan. This plan covers your emotional health, primary care needs, medication side effects, and nutrition, among other areas.
Leadership in Neuroendocrine Tumor Care
In addition to participation in clinical research, our team is advancing care for neuroendocrine tumors for patients natiowide through close involvement with these organizations:
National Cancer Institute’s (NCI) Neuroendocrine Tumor Taskforce
ECOG-ACRIN NET Cancer Research Working Group
North American Neuroendocrine Tumor Society’s (NANETS) Guidelines and Executive Committees
National Comprehensive Cancer Network (NCCN) Neuroendocrine Tumors Guidelines Panel
NET Research Fund
Our doctors are actively involved in clinical research and have served as principal investigators for recent FDA-approved neuroendocrine tumor treatments. We offer multiple clinical trials for patients with neuroendocrine tumors.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
HOW TO REFER
Fax a referral form with supporting documentation to 650-320-9443.
Please note, though this form is from Stanford Health Care, it is also used for all Cancer Center referrals.
Track your patients' progress and communicate with Stanford providers securely online.